	US 11,987,578 B1
	7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Antar Ahmed Abdelhamid Ahmed, Sohag (EG); and Amer A. Amer, Sohag (EG)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Feb. 6, 2024, as Appl. No. 18/434,601.
Application 18/434,601 is a division of application No. 18/369,782, filed on Sep. 18, 2023.
Int. Cl. C07D 417/12 (2006.01); A61P 29/00 (2006.01)

CPC C07D 417/12 (2013.01) [A61P 29/00 (2018.01)]

1 Claim

1. A method of treating inflammation in a patient comprising administering to a patient in need thereof a therapeutically effective amount of 7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid.